SCHEMBL24577220

SCHEMBL24577220

COCCn1cc(-c2cn3ncc(C(=O)Nc4cc(NC(=O)CCCCl)cnc4C)c3s2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 6/20 0.40
▸ TBK1 Q9UHD2 6/20 0.40
▸ JAK2 O60674 3/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ JAK1 P23458 3/20 0.33
▸ TYK2 P29597 3/20 0.33
▸ JAK3 P52333 3/20 0.33
▸ KAT5 Q92993 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAP3K7 O43318 1/20 0.32
▸ RET P07949 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ PRKAA1 Q13131 1/20 0.32
▸ ROCK1 Q13464 1/20 0.32
▸ MAP3K5 Q99683 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ IRAK4 Q9NWZ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29759874 1.00 IKBKE (0.40) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577629 0.96 IKBKE (0.41) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL29759547 0.96 IKBKE (0.41) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL29759532 0.93 IKBKE (0.42) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577285 0.93 IKBKE (0.42) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577195 0.91 IKBKE (0.38) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL29759578 0.89 CSF1R (0.40) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24577482 0.89 IKBKE (0.43) IKBKETBK1JAK2JAK1TYK2
SCHEMBL24578740 0.89 CSF1R (0.40) IKBKETBK1JAK2HDAC1HDAC6
SCHEMBL24578953 0.88 IKBKE (0.44) IKBKETBK1JAK2JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback